PacificHealth Laboratories, Inc. (PHLI) Research
PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery. PHLI's product line includes notable items like ENDUROX R4, a drink formulated for muscle recovery; ACCELERADE, a protein-powered sports beverage; energy gels such as ACCEL GEL and 2ND SURGE; the exercise supplement ENDUROX EXCEL; and Body Glove Surge. Additionally, they provide ACCELERADE HYDRO, a specific formulation for less intense workouts, which supports hydration, energy, and recovery before, during, and after physical activity. Reaching consumers through diverse distribution channels, PHLI's products are available in sports specialty and natural product retailers and chains, as well as directly through their official website. PacificHealth Laboratories, Inc. was founded in 1995 and is headquartered in Matawan, New Jersey.
Market snapshot
- Symbol
- PHLI
- Price
- $0.00
- Day change
- +9900.00%
- Market cap
- $438.3K
- P/E ratio
- -0.00x
- 52-week range
- 0.000001-0.0001
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
Peer companies
Recent insider activity
- Mizel Adam — A-Award (73171 shares) on 2010-06-30
- Mizel Adam — A-Award (70588 shares) on 2010-03-31
- Mizel Adam — A-Award (42857 shares) on 2009-12-31
- Mizel Adam — A-Award (23077 shares) on 2009-09-30
- Mizel Adam — P-Purchase (5000 shares) on 2009-09-08
Open PacificHealth Laboratories, Inc. (PHLI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.